EcoDrugPlus

Matrix Metallopeptidase 9

Ensembl ID : ENSLCAG00010006164
Gene Symbol: LOC108876510
4 Cross references
215 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSLCAG00010002119
Gene Symbol: MTOR
1 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSLCAG00010003451
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSLCAG00010027458
Gene Symbol: MC4R
1 Cross references
89 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSLCAG00010019686
Gene Symbol: MTNR1AA
4 Cross references
186 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSLCAG00010002933
Gene Symbol: MME
4 Cross references
231 Possible Orthologues:

Methionyl Aminopeptidase 2a

Ensembl ID : ENSLCAG00010026892
Gene Symbol: METAP2A
4 Cross references
220 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSLCAG00010024083
Gene Symbol: LOC108891348
4 Cross references
209 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSLCAG00010004236
Gene Symbol: LOC108874078
4 Cross references
88 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSLCAG00010008943
Gene Symbol: MAPK11
4 Cross references
199 Possible Orthologues:

Mitogen-Activated Protein Kinase 14a

Ensembl ID : ENSLCAG00010006895
Gene Symbol: MAPK14A
1 Cross references
206 Possible Orthologues:

Mitogen-Activated Protein Kinase 14b

Ensembl ID : ENSLCAG00010003698
Gene Symbol: MAPK14B
1 Cross references
224 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).